Direkt zum Inhalt
Merck
  • Temporal profile and mechanisms of the prompt sympathoexcitation following coronary ligation in Wistar rats.

Temporal profile and mechanisms of the prompt sympathoexcitation following coronary ligation in Wistar rats.

PloS one (2014-07-10)
Luciana Mesquita Passamani, Ana Paula Abdala, Davi José de Almeida Moraes, Karla Nívea Sampaio, José Geraldo Mill, Julian Francis Richmond Paton
ZUSAMMENFASSUNG

Our aim was to assess the timing and mechanisms of the sympathoexcitation that occurs immediately after coronary ligation. We recorded thoracic sympathetic (tSNA) and phrenic activities, heart rate (HR) and perfusion pressure in Wistar rats subjected to either ligation of the left anterior descending coronary artery (LAD) or Sham operated in the working heart-brainstem preparation. Thirty minutes after LAD ligation, tSNA had increased (basal: 2.5±0.2 µV, 30 min: 3.5±0.3 µV), being even higher at 60 min (5.2±0.5 µV, P<0.01); while no change was observed in Sham animals. HR increased significantly 45 min after LAD (P<0.01). Sixty minutes after LAD ligation, there was: (i) an augmented peripheral chemoreflex - greater sympathoexcitatory response (50, 45 and 27% of increase to 25, 50 and 75 µL injections of NaCN 0.03%, respectively, when compared to Sham, P<0.01); (ii) an elevated pressor response (32±1 versus 23±1 mmHg in Sham, P<0.01) and a reduced baroreflex sympathetic gain (1.3±0.1 versus Sham 2.0±0.1%.mmHg-1, P<0.01) to phenylephrine injection; (iii) an elevated cardiac sympathetic tone (ΔHR after atenolol: -108±8 versus -82±7 bpm in Sham, P<0.05). In contrast, no changes were observed in cardiac vagal tone and bradycardic response to both baroreflex and chemoreflex between LAD and Sham groups. The immediate sympathoexcitatory response in LAD rats was dependent on an excitatory spinal sympathetic cardiocardiac reflex, whereas at 3 h an angiotensin II type 1 receptor mechanism was essential since Losartan curbed the response by 34% relative to LAD rats administered saline (P<0.05). A spinal reflex appears key to the immediate sympathoexcitatory response after coronary ligation. Therefore, the sympathoexcitatory response seems to be maintained by an angiotensinergic mechanism and concomitant augmentation of sympathoexcitatory reflexes.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Kaliumphosphat, ACS reagent, ≥99.0%
Sigma-Aldrich
Natriumbicarbonat, ACS reagent, ≥99.7%
Sigma-Aldrich
Natriumbicarbonat, powder, BioReagent, for molecular biology, suitable for cell culture, suitable for insect cell culture
Sigma-Aldrich
Natriumbicarbonat, ReagentPlus®, ≥99.5%, powder
Sigma-Aldrich
Kaliumphosphat, powder, suitable for cell culture, suitable for insect cell culture, suitable for plant cell culture, ≥99.0%
Sigma-Aldrich
Natriumbicarbonat, anhydrous, free-flowing, Redi-Dri, ACS reagent, ≥99.7%
Sigma-Aldrich
Kaliumphosphat, for molecular biology, ≥98.0%
Sigma-Aldrich
Natriumbicarbonat, puriss., meets analytical specification of Ph. Eur., BP, USP, FCC, E500, 99.0-100.5%, powder
USP
Natriumbicarbonat, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
[Arg8]-Vasopressin -acetat (Salz), ≥95% (HPLC)
Sigma-Aldrich
Kaliumphosphat, BioUltra, for molecular biology, anhydrous, ≥99.5% (T)
Sigma-Aldrich
Kaliumphosphat, ReagentPlus®
Sigma-Aldrich
Natriumbicarbonat, anhydrous, free-flowing, Redi-Dri, ReagentPlus®, ≥99.5%
Sigma-Aldrich
Kaliumphosphat, 99.99% trace metals basis
Sigma-Aldrich
Natriumbicarbonat, BioXtra, 99.5-100.5%
USP
Losartan-Kalium, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Natriumbicarbonat, −40-+140 mesh, ≥95%
USP
Monobasisches Kaliumphosphat, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Vecuroniumbromid
Sigma-Aldrich
Natriumbicarbonat-12C, 13C-depleted, 99.9 atom % 12C
Sigma-Aldrich
Kaliumphosphat, tested according to Ph. Eur., anhydrous
Supelco
Kaliumphosphat, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Losartan-Kalium
Sigma-Aldrich
Natriumbicarbonat, tested according to Ph. Eur.
USP
Vecuroniumbromid, United States Pharmacopeia (USP) Reference Standard
Losartan-Kalium, European Pharmacopoeia (EP) Reference Standard
Vecuroniumbromid, European Pharmacopoeia (EP) Reference Standard